Feb 21, 2024 / 09:00AM GMT
Operator
Good day, ladies and gentlemen, and welcome to the Adcock Ingram Group interim results for the 6 months ended 31 December, 2023. (Operator Instructions) Also note, this event is being recorded.
I will now hand the conference over to the Chief Executive Officer, Mr. Andy Hall. Please go ahead, sir.
Andrew Hall - Adcock Ingram Holdings Ltd - Chief Executive Officer, Executive Director
Thank you, Chris. Good morning, ladies and gentlemen, and welcome to our interim results webcast for the 6 months ended 31 December, '23. We know it's a busy day with the budget speech, so we appreciate you taking the time to join the webcast.
I'll take you through an overview of what we consider to be a resilient performance attributed to our defensive product portfolio, good work from our sales and marketing teams and focus on customer service in the distribution division.
According to IQVIA, the company that measures pharmaceutical market shares, Adcock Ingram has retained its status as the #1 pharmaceutical company in the South African private market.
Half Year 2024 Adcock Ingram Holdings Ltd Earnings Call Transcript
Feb 21, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers